1. Home
  2. GB vs ANIP Comparison

GB vs ANIP Comparison

Compare GB & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GB
  • ANIP
  • Stock Information
  • Founded
  • GB 1980
  • ANIP 2001
  • Country
  • GB Switzerland
  • ANIP United States
  • Employees
  • GB N/A
  • ANIP N/A
  • Industry
  • GB EDP Services
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • GB Technology
  • ANIP Health Care
  • Exchange
  • GB Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • GB 1.5B
  • ANIP 1.4B
  • IPO Year
  • GB N/A
  • ANIP N/A
  • Fundamental
  • Price
  • GB $7.35
  • ANIP $64.96
  • Analyst Decision
  • GB Buy
  • ANIP Strong Buy
  • Analyst Count
  • GB 1
  • ANIP 9
  • Target Price
  • GB $6.00
  • ANIP $80.56
  • AVG Volume (30 Days)
  • GB 46.7K
  • ANIP 262.0K
  • Earning Date
  • GB 08-27-2025
  • ANIP 08-05-2025
  • Dividend Yield
  • GB N/A
  • ANIP N/A
  • EPS Growth
  • GB 483.33
  • ANIP N/A
  • EPS
  • GB 0.38
  • ANIP N/A
  • Revenue
  • GB $548,939,689.00
  • ANIP $674,068,000.00
  • Revenue This Year
  • GB $15.17
  • ANIP $30.52
  • Revenue Next Year
  • GB $6.50
  • ANIP $7.40
  • P/E Ratio
  • GB $19.32
  • ANIP N/A
  • Revenue Growth
  • GB 20.26
  • ANIP 30.27
  • 52 Week Low
  • GB $4.29
  • ANIP $52.50
  • 52 Week High
  • GB $8.00
  • ANIP $77.00
  • Technical
  • Relative Strength Index (RSI)
  • GB 38.93
  • ANIP 52.40
  • Support Level
  • GB $7.45
  • ANIP $63.17
  • Resistance Level
  • GB $7.49
  • ANIP $66.97
  • Average True Range (ATR)
  • GB 0.04
  • ANIP 1.79
  • MACD
  • GB -0.02
  • ANIP -0.01
  • Stochastic Oscillator
  • GB 29.55
  • ANIP 42.12

About GB Global Blue Group Holding AG

Global Blue Group Holding AG offers a seamless shopping and payment journey for tourists and also provides a wide range of Added-Value Payment Solutions for all the stakeholders involved, including retailers and international shoppers. The company connect thousands of retailers, acquirers, and hotels with nearly 80 million consumers across more than 50 countries, in three industries: Tax Free Shopping, Payments and Post-Purchase solutions.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: